These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2418010

  • 1. Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment.
    Modai I, Beigel Y, Cygielman G.
    J Clin Psychiatry; 1986 Feb; 47(2):92-3. PubMed ID: 2418010
    [Abstract] [Full Text] [Related]

  • 2. Monoamine metabolism during chronic benzodiazepine treatment and withdrawal.
    Petursson H, Bond PA, Smith B, Lader MH.
    Biol Psychiatry; 1983 Feb; 18(2):207-13. PubMed ID: 6187380
    [Abstract] [Full Text] [Related]

  • 3. Phenelzine in depressed patients. Effects on urinary MHPG excretion in relation to clinical response.
    Beckmann H, Murphy DL.
    Neuropsychobiology; 1977 Feb; 3(1):49-55. PubMed ID: 895998
    [Abstract] [Full Text] [Related]

  • 4. Platelet MAO inhibition, urinary MHPG, and leukocyte beta-adrenergic receptors in depressed patients treated with phenelzine.
    Sharma RP, Janicak PG, Javaid JI, Pandey GN, Gierl B, Davis JM.
    Am J Psychiatry; 1990 Oct; 147(10):1318-21. PubMed ID: 2169208
    [Abstract] [Full Text] [Related]

  • 5. Biological markers in depression. Monoamine metabolites in urine of depressed patients and normal subjects.
    Vandel S, Vandel B, Bonin B, Camejo Z, Sandoz M, Allers G, Volmat R.
    Pharmacopsychiatry; 1985 Nov; 18(6):347-50. PubMed ID: 2418451
    [Abstract] [Full Text] [Related]

  • 6. Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine.
    Shekim WO, Javaid J, Davis JM, Bylund DB.
    Biol Psychiatry; 1983 Jun; 18(6):707-14. PubMed ID: 6871304
    [Abstract] [Full Text] [Related]

  • 7. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S.
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [Abstract] [Full Text] [Related]

  • 8. Asthma and alcohol withdrawal as sources of artefact in urinary excretion of 3-methoxy-4-hydroxyl phenylglycol (MHPG).
    Hollister LE, Prusmack JJ, Knopes K, Kanaske K.
    Commun Psychopharmacol; 1980 Oct; 4(2):135-40. PubMed ID: 7428334
    [No Abstract] [Full Text] [Related]

  • 9. Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment.
    Murphy DL, Brand E, Goldman T, Baker M, Wright C, van Kammen D, Gordon E.
    J Nerv Ment Dis; 1977 Feb; 164(2):129-34. PubMed ID: 836485
    [Abstract] [Full Text] [Related]

  • 10. Reliability of urinary monoamine and metabolite output measurements in depressed patients.
    Linnoila M, Karoum F, Miller T, Potter WZ.
    Am J Psychiatry; 1983 Aug; 140(8):1055-7. PubMed ID: 6191580
    [Abstract] [Full Text] [Related]

  • 11. Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys.
    Shekim WO, Javaid J, Dekirmenjian H, Chapel JL, Davis JM.
    Am J Psychiatry; 1982 Apr; 139(4):485-8. PubMed ID: 7065295
    [Abstract] [Full Text] [Related]

  • 12. Low level of urinary 5-hydroxyindole acetic acid (5 HIAA) in obese children having concomitantly high 3-methoxy-4-hydroxyphenyl glycol (MHPG) excretion.
    Popa M, Stefănescu AM, Dumitriu L.
    Endocrinologie; 1989 Apr; 27(1):29-34. PubMed ID: 2474191
    [Abstract] [Full Text] [Related]

  • 13. Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.
    Maas JW, Koslow SH, Katz MM, Bowden CL, Gibbons RL, Stokes PE, Robins E, Davis JM.
    Am J Psychiatry; 1984 Oct; 141(10):1159-71. PubMed ID: 6207736
    [Abstract] [Full Text] [Related]

  • 14. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
    Bieck PR, Firkusny L, Schick C, Antonin KH, Nilsson E, Schulz R, Schwenk M, Wollmann H.
    Clin Pharmacol Ther; 1989 Mar; 45(3):260-9. PubMed ID: 2920501
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Biogenic amine metabolites in delusional (psychotic) depression and melancholia subtypes of major depression.
    Lykouras L, Markianos M, Hatzimanolis J, Malliaras D, Stefanis C.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1261-71. PubMed ID: 7532316
    [Abstract] [Full Text] [Related]

  • 17. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
    Schildkraut JJ, Orsulak PJ, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA, LaBrie RA.
    Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878
    [Abstract] [Full Text] [Related]

  • 18. Urinary 3-methyoxy-4-hydroxyphenylglycol and homovanillic acid response to d-amphetamine in hyperactive children.
    Brown GL, Ebert MH, Hunt RD, Rapoport JL.
    Biol Psychiatry; 1981 Aug; 16(8):779-87. PubMed ID: 7197170
    [No Abstract] [Full Text] [Related]

  • 19. Urinary excretion of catechol metabolites particularly MHPG in children. Relation to age, body mass indices and thyroid function.
    Popa M, Stefănescu AM, Dumitriu L.
    Endocrinologie; 1986 Aug; 24(3):203-14. PubMed ID: 3775226
    [Abstract] [Full Text] [Related]

  • 20. Neuropsychological correlates of urinary amine metabolites in Tourette's syndrome.
    Bornstein RA, Baker GB.
    Int J Neurosci; 1988 Sep; 42(1-2):113-20. PubMed ID: 2463232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.